1 Sung HJ, "Vasoconstriction potency induced by aminoamide local anesthetics correlates with lipid solubility" 2012 : 170958-, 2012
2 Hollenberg SM, "Vasoactive drugs in circulatory shock" 183 : 847-855, 2011
3 Ozcan MS, "Update on the use of lipid emulsions in local anesthetic systemic toxicity: a focus on differential efficacy and lipid emulsion as part of advanced cardiac life support" 49 : 91-103, 2011
4 Cox B, "Toxicity of local anaesthetics" 17 : 111-136, 2003
5 Liu L, "The comparative effects of lipid, epinephrine, and their combination in the reversal of bupivacaine-induced asystole in the isolated rat heart" 114 : 886-893, 2012
6 Tanoubi I, "Systemic toxicity with mepivacaine following axillary block in a patient with terminal kidney failure" 25 : 33-35, 2006
7 Santos AC, "Systemic toxicity of ropivacaine during ovine pregnancy" 75 : 137-141, 1991
8 Mertes N, "Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study" 50 : 253-259, 2006
9 Sakai T, "Ropivacaine-induced late-onset systemic toxicity after transversus abdominis plane block under general anesthesia: successful reversal with 20% lipid emulsion" 59 : 1502-1505, 2010
10 Heavner JE, "Resuscitation from bupivacaine-induced asystole in rats: comparison of different cardioactive drugs" 80 : 1134-1139, 1995
1 Sung HJ, "Vasoconstriction potency induced by aminoamide local anesthetics correlates with lipid solubility" 2012 : 170958-, 2012
2 Hollenberg SM, "Vasoactive drugs in circulatory shock" 183 : 847-855, 2011
3 Ozcan MS, "Update on the use of lipid emulsions in local anesthetic systemic toxicity: a focus on differential efficacy and lipid emulsion as part of advanced cardiac life support" 49 : 91-103, 2011
4 Cox B, "Toxicity of local anaesthetics" 17 : 111-136, 2003
5 Liu L, "The comparative effects of lipid, epinephrine, and their combination in the reversal of bupivacaine-induced asystole in the isolated rat heart" 114 : 886-893, 2012
6 Tanoubi I, "Systemic toxicity with mepivacaine following axillary block in a patient with terminal kidney failure" 25 : 33-35, 2006
7 Santos AC, "Systemic toxicity of ropivacaine during ovine pregnancy" 75 : 137-141, 1991
8 Mertes N, "Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study" 50 : 253-259, 2006
9 Sakai T, "Ropivacaine-induced late-onset systemic toxicity after transversus abdominis plane block under general anesthesia: successful reversal with 20% lipid emulsion" 59 : 1502-1505, 2010
10 Heavner JE, "Resuscitation from bupivacaine-induced asystole in rats: comparison of different cardioactive drugs" 80 : 1134-1139, 1995
11 Sung HJ, "Mepivacaine-induced contraction is attenuated by endothelial nitric oxide release in isolated rat aorta" 90 : 863-872, 2012
12 Huang JM, "Long-chain fatty acids activate calcium channels in ventricular myocytes" 89 : 6452-6456, 1992
13 Schaeffer E, "Local anaesthetics intoxication, during ultrasound-guided axillary plexus block, treated by Intralipide" 29 : 929-930, 2010
14 Cassidy SL, "Lipid solubility of a series of drugs and its relevance to fatal poisoning" 40 : 130-132, 1988
15 Weinberg GL, "Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart" 31 : 296-303, 2006
16 Ok SH, "Lipid emulsion reverses Levobupivacaine-induced responses in isolated rat aortic vessels" 114 : 293-301, 2011
17 Weinberg GL, "Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose" 117 : 180-187, 2012
18 Weinberg G, "Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity" 28 : 198-202, 2003
19 Foxall G, "Levobupivacaine-induced seizures and cardiovascular collapse treated with Intralipid" 62 : 516-518, 2007
20 Baik JS, "Levobupivacaine-induced contraction of isolated rat aorta is calcium dependent" 89 : 467-476, 2011
21 Zapata-Sudo G, "Is comparative cardiotoxicity of S(-) and R(+) bupivacaine related to enantiomer-selective inhibition of L-type Ca(2+) channels?" 92 : 496-501, 2001
22 Waring WS, "Intravenous lipid administration for drug-induced toxicity: a critical review of the existing data" 5 : 437-444, 2012
23 Dix SK, "Intractable cardiac arrest due to lidocaine toxicity successfully resuscitated with lipid emulsion" 39 : 872-874, 2011
24 Strichartz GR, "Fundamental properties of local anesthetics. II. Measured octanol:buffer partition coefficients and pKa values of clinically used drugs" 71 : 158-170, 1990
25 Harvey M, "Epinephrine injection in lipid-based resuscitation from bupivacaine-induced cardiac arrest: transient circulatory return in rabbits" 111 : 791-796, 2010
26 Hiller DB, "Epinephrine impairs lipid resuscitation from bupivacaine overdose: a threshold effect" 111 : 498-505, 2009
27 Charbonneau H, "Early use of lipid emulsion to treat incipient mepivacaine intoxication" 34 : 277-278, 2009
28 Sung HJ, "Direct effect of ropivacaine involves lipoxygenase pathway activation in rat aortic smooth muscle" 56 : 298-306, 2009
29 Montiel V, "Diltiazem poisoning treated with hyperinsulinemic euglycemia therapy and intravenous lipid emulsion" 18 : 121-123, 2011
30 옥성호, "Dexmedetomidine-induced contraction of isolated rat aorta is dependent on extracellular calcium concentration" 대한마취통증의학회 63 (63): 253-259, 2012
31 Groban L, "Central nervous system and cardiac effects from long-acting amide local anesthetic toxicity in the intact animal model" 28 : 3-11, 2003
32 Li B, "Association of sustained cardiovascular recovery with epinephrine in the delayed lipid-based resuscitation from cardiac arrest induced by bupivacaine overdose in rats" 108 : 857-863, 2012